Fred Aslan insider trades
Open-market stock purchases and sales by Fred Aslan, Chief Executive Officer at Artiva Biotherapeutics, Inc, from SEC Form 4 filings since Jul 18, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 19, 2026 | ARTV Artiva Biotherapeutics, Inc | Sold | $244K |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc | Bought (not open market) | — |
| Feb 15, 2026 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $58.4K |
| Dec 15, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold | $19.1K |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Bought (not open market) | — |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $504K |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $258K |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $1.3M |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $137K |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $1.5M |
| Dec 12, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $3.8M |
| Nov 17, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold | $21.5K |
| Nov 15, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold (not open market) | $20.6K |
| Oct 17, 2025 | ARTV Artiva Biotherapeutics, Inc | Sold | $153K |
Companies traded
- ARTV Artiva Biotherapeutics, Inc: 5 sales, last May 19, 2026